News | November 27, 2025
Lords Mark bets big on AI-driven dialysis tech, buys 85% stake in Renalyx Health
Renalyx will continue operating as an independent unit within the group
Renalyx will continue operating as an independent unit within the group
The State’s PPP model has already mobilised Rs. 150 crore in core infrastructure, while Thermo Fisher has invested Rs. 90 crore in the Bioprocess Design Centre and its co-located Customer Experience Centre
The new Bioprocess Design Center will serve as a cutting-edge scale-up hub for biologics and vaccine manufacturing
The 2025 edition of the EdelGive Hurun list recognizes 24 exceptional women leaders for their philanthropic impact across critical areas
_256_384.png)
Over 700 exhibitors from APAC, Europe, the US, and beyond showcased the latest in personal care innovation
The facility will offer fully equipped wet labs and strategic scientific support for early-stage biotech companies
Both companies will jointly execute development and scale-up of multiple strategic APIs, including late-stage NCE-1 opportunities
With US$ 30.46 billion in exports and robust manufacturing capabilities, the industry is poised to expand into high-value drugs while strengthening ESG and compliance standards
Subscribe To Our Newsletter & Stay Updated
